ÂÜÀòÂÒÂ×

Sridhar Jaligama, PhD, DABT, Manager of Inhalation Toxicology. He is a board-certified toxicologist with over 10 years of experience in the design and conduct of complex toxicology programs. He has broad experience as a Study Director in several areas of non-clinical toxicology and with a specific expertise in inhalation and respiratory toxicology. In this role, he has led the design and conduct of complex non-clinical toxicology studies in compliance with FDA GLP regulations. He has led acute, subchronic, and chronic inhalation studies performed via nose-only and whole body inhalation exposure routes, and is proficient at in-depth technical reviews, data interpretation, and report preparation in compliance with the regulatory guidelines.

In his previous roles, Dr. Jaligama has led multiple inhalation toxicology study teams in programs involving a wide range of test articles. He is experienced in coordinating and managing toxicology research projects involving cross-functional teams. In addition to conducting programs to meet regulatory requirements, Dr. Jaligama has led a team to develop and validate new capabilities in pulmonary function measurement; implemented a formal training program for technicians; and served as contributing scientist for several phases of GLP studies.

Dr. Jaligama has a deep understanding of FDA Tobacco Deeming Regulations and Pre-market Tobacco Application requirements, and has served as the single point of technical contact for large toxicology programs conducted in support of Pre-market Tobacco Applications to FDA. He is an author/co-author of more than 50 publications and posters/presentations.